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A completely diverting portocaval shunt (Eck's fistula) pro-
foundly alters the structure and function of the liver in several 
species. Until recently, these changes were thought in what has 
been termed the "flow hypothesis"(l) to be caused by and to be 
proportionate to the reduction in total hepatic blood-flow which 
the procedure causes. We have suggested instead, that disruption 
of normal endogenous insulin delivery to the liver for determin-
ing this lesions was mainly responsible. We showed that infusion 
of commercial insulin into the tied-off central portal vein of 
dogs prevented most of the acute atrophic changes that are ordi-
narily very advanced by light microscopy within four days after 
portocaval shunt. 
Much of the evidence supporting the importance of insulin as 
an hepatotrophic factor has to do with what happens when the 
liver is deprived of portal venous blood or that portion of por-
tal blood that emanates from the pancreas. 
The light microscopic changes in the liver caused by portal 
blood deprivation include atrophy, fatty infiltration, and degly-
cogenation (10) Ultrastructurally, the most striking and specific 
changes are depletion and disruption of the rough endoplasmic re-
ticulum, and reduction in the membrane-bound ribosomes. All these 
events occur with surprising speed, being about 90% complete 
within four days. We also know from other work recently summa-
rized by Putnam el al. (7) that the same general light and elec-
tron microscopic changes have been seen after portal d.iversion in 
the livers of rats, dogs, swine, baboons, and humans with some 
variations in degree. Thus, the hepatic injury of Eck fistula is 
common to all species so far studied. The metabolic consequences 
have been the mildest in rats and man. 
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Fig.1. Experiments in which Eck fistula is performed and post-
operative infusions are made into the left portal vein. (From 
Starzl et ale (1976) by permission of The Lancet.) 
Fig. 1 represents the direct test to demonstrate that the li-
ver alteration of Eck fistula is caused by deprivation of liver 
of direct access to endogenous insulin. Seventy dogs were infused 
with a fine infusion catheter placed into the tied-off left 
portal branch and led trough the body wall and trough along sub-
cutaneous tunnel 
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reported in table 2 demonstrate that insulin 
the acute atrophy that otherwise halved the size 
of the cells and preserved hepatocyte ultrastructure. In small 
doses, glucagon did not potentiate the action of insulin, and, in 
large doses, it may have reduced the insulin benefit. Glucagon 
alone in either small or large doses had no effect under the con-
ditions of this experimental model. 
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TABLE 1 • 
Group N° of Type of Insulin* Glucagon 
N° exp infusion (units/Kg/day (mg/Kg/day 
mean ± SD) mean ± SD) 
1 11 No treatment 0 0 
2 6 Hepar. saline 0 0 
3 13 Large dose ins. 0.43 ± 0.05 0 
4 4 Small dose ins. 0.16:t0.ll 0 
5 8 Purified ins. 0.42 ± 9.08 0 
6 8 Small dose glue. 0 0.0053 ± 0.0011 
7 6 Large dose glue. 0 0.60 ± 0.10 
8 7 2/1 ins./gluc. 0.45 ± 0.03 0.0053 ± 0.0005 
9 7 2/100 ins. /glue. 0.42 ± 0.01 0.5 ± 0.02 
*All insulin was commercial regular insulin, except in Group 5 
Table 2. 
Group Cell size units (mean + SD) P values* 
N° (L4 vs R4) 
LO L4 R4 
1 0.197 ± 0.04 0.108 ± 0.02 0.108 ± 0.02 N.S. 
2 0.200 ± 0.04 0.105 ± 0.02 0.104 ± 0.01 N. S. 
3 0.189 ± 0.03 0.160 ± 0.02 0.100 t 0.02 <0.001 
4 0.194 + 0.04 0.143 ± 0.02 0.094 ± 0.01 <0.05 
5 0.196 ± 0.04 0.158 ± 0.01 0.095 ± 0.02 <0.001 
6 0.189 ± 0.01 0.103 ± 0.01 0.103 ± 0.01 N. S. 
7 0.165 ± 0.03 0.085 ± 0.01 0.082 i- 0.01 N.S. 
8 0.211 ± 0.05 0.156 ± 0.05 0.094 ± 0.02 <0.05 
9 0.215 ± 0.04 0.114 t 0.03 0.073 ± 0.02 <0.05 
* Comparisons were by Student's t test. 
The effect of insulin on hepatocyte proliferation was also 
striking, as reported in table 3. After Eck fistula, the mitotic 
rate was increased to about three times normal, from 1.5 to 4.5 
per 1000 cells. Insulin more than tripled this cell renewal, with 
no spill-over to the controlateral lobes. Glucagon alone had no 
effect, nor did it potentiate the action of insulin. 
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Table 3. 
N° of labelled hepatocytes 
per 1000 epatocytes P values'" 
Group (mean ± SD) (L4 vs R4) 
N° L4 R4 
4.9 ± 1.0 4.7 ± 0.9 N.S. 
2 4.6 ± 0.8 4.7 ± 0.9 N.S. 
3 13.0 ± 3.9 4.6 ± 0.9 < 0.001 
4 15.6 ± 2.0 5.3 ± 1.0 < 0.001 
5 14.4 ± 1.1 4.8 ± 1.0 < 0.001 
6 4.9 ± 0.9 4.3 ± 0.6 < 0.05 
7 4.2 ± 1.5 4.3 ± 1.1 N.S. 
8 1l.8 ± 1.2 4.5 ± 0.8 < 0.001 
9 14.8 ± 1.0 4.5 ± 0.9 < 0.001 
*Comparisons were by Student's t test. 
In unaltered or sham-operated dogs the left and 
values respectively were 1.6 t 0.4 and 1.6:t0.5. 
caused by Eck fistula is significant'( P < 0.001). 
CONCLUSIONS 
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left lobar hepatocyte atrophy, permitted the ultrastructure of 
the protected liver cells to remain essentially normal, and cau-
sed a threefold increase in the number of left lobar hepatocytes 
undergoing mitosis. There was no spill-over effect in the right 
lobes. Glucagon by itself did not cause any of these changes, and 
it did not potentiate them when added to insulin at a 2/1 molar 
insulin/glucagon ratio. At a dose 100 times greater, glucagon may 
actually have reduced the benefit from insulin. 
Thus, it has been established that "hepatic insulinopenia" is 
the most important element in the liver injury of Eck fistula. It 
is ironic that this answer was so close to detection all the 
time. Hahn et al. (2) definitely emphasized more than 80 years 
ago that, 
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of course the endocrinological significance of that fact was not 
then known. Because of that same ignorance of hormones, specula-
tion by Rous and Larimore (9) was vague about the possibility, as 
they saw it in 1920, that portal blood might have special liver-
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supporting constituents. A perplexing observation of our own from 
almost 20 years ago contained a strong clue (6). It was noticed 
that dogs with Eck fistula plus insulin-treated alloxan diabetes 
remained in much better health than animals with Eck fistula 
alone in that the diabetic dogs gained weight and were spared all 
evidence of encephalopathy. The now-obvious explanation ~~ that 
peripheral insulin concentrations of two to three times normal 
are required in diabetics to maintain normoglycaemia when insulin 
is given systemically, thus inadvertently providing a compensa-
tory hepatic arterial increase in the hormone. Conversely, in un-
treated alloxan-diabetic rats with unaltered hepatic circulation. 
Reaven, Peterson, and Reaven (8) have demonstrated acute ultra-
structural changes in the liver cells that were remarkably like 
those caused by Eck fistula. 
Another aspect which is related with this result is the role 
of insulin in the area of cell growth control and regeneration. 
The provision of exogenous insulin in the present studies pro-
voked a sustained burst of proliferation beyond the already 
heightened mitotic background. 
These results were consistent with those in the important 
study by Younger, King, and Steiner (15) who allowed rats to be 
alloxan-diabetic for a month before treating them with insulin. 
Although the livers were thought to already contain a higher than 
normal number of hepatocytes, the proliferative response to insu-
lin was spectacular, being similar to that after a 68% liver 
resection. However, Younger and his colleagues also showed that 
diabetic rats retained a potent although subnormal ability to re-
generate their livers after an actual hepatic resection, even if 
insulin treatment was withheld. Accordingly, it is unlikely that 
any single control factor will be the sole explanation of regen-
eration. Holley (3) and Leffert (4) have summarized the dozens of 
substances, hormonal (including insulin) and others, that can 
initiate and regulate cell growth in tissue-culture systems. 
There is no reason to doubt the relevance of their comments con-
cerning the complexities of growth control to in-vivo situations. 
The conclusion on the basis of this clear experiment is that in-
sulin is the most important factor in controlling hepatocyte 
structure and function, and that, furthermore, it shows some ac-
tivity in liver regeneration not yet fully understood (14). 
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